SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.22-0.7%12:21 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Fred Ayres who wrote (31)11/19/1996 7:53:00 PM
From: Gerald Thomas   of 455
 
The PRO 2000 systemic trial, being conducted at the St. Pierre Hospital of the
Free University of Brussels, Belgium, is nearing its mid-point. The Company has
completed dosing two of the four escalating dose groups, and, depending on the
analysis of data from these groups, currently expects to complete dosing during
the first half of 1997.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext